MYLLE PHARMA
0566.940.155 · rovalta.com · 25/09/2026
ACTIVE
MYLLE PHARMA
Financial year 2025 · Closed on 30/09/2025
Net result128,2 k €+44,4 %over 1 year
Gross margin68,5 k €-12,9 %over 1 year
Equity478,6 k €-18,9 %over 1 year
Overview
Identity
Source · BCE/KBOMYLLE PHARMA is a Private limited company incorporated in 2014. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Anzegem.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0566.940.155
- Incorporation
- 29/10/2014
- Legal form
- Private limited company
- Registered office
- Stijn Streuvelsstraat 26
8570 Anzegem · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 30/09/2025
Activities (NACE)
47730Dispensing chemist in specialised stores· main47730Dispensing chemist in specialised stores47740Retail sale of medical and orthopaedic goods in specialised stores47741Retail sale of medical and orthopaedic goods in specialised stores47750Retail sale of cosmetic and toilet articles in specialised stores47750Retail sale of cosmetic and toilet articles in specialised stores
Signals
ProfitableSolid equityLow riskPositive cashflowPositive EBITDA
Financials
Source · NBB, 11 filingsTrend over 11 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 68,5 k € | -12.9% | 78,6 k € | +8.8% | 72,3 k € | -2.9% | 74,4 k € | +8.4% | 68,7 k € |
| EBITDA | 65,6 k € | -12.8% | 75,2 k € | +7.4% | 70 k € | -3.4% | 72,5 k € | +8.7% | 66,7 k € |
| Operating result | 63,2 k € | -13.4% | 73 k € | +5.9% | 68,9 k € | -4.0% | 71,8 k € | +8.7% | 66,1 k € |
| Net result | 128,2 k € | +44.4% | 88,8 k € | -8.3% | 96,8 k € | -0.2% | 97 k € | +8.4% | 89,5 k € |
| Balance sheet | |||||||||
| Equity | 478,6 k € | -18.9% | 590,4 k € | +7.0% | 551,6 k € | +21.3% | 454,8 k € | +27.1% | 357,8 k € |
| Total assets | 947,5 k € | -1.6% | 963,1 k € | +0.9% | 954,8 k € | +5.3% | 906,5 k € | -7.6% | 981,6 k € |
| Cash | 78,4 k € | -17.6% | 95,1 k € | +26.0% | 75,5 k € | +66.6% | 45,3 k € | -62.0% | 119,2 k € |
| Debts | 469 k € | +25.8% | 372,7 k € | -7.6% | 403,2 k € | -10.7% | 451,7 k € | -27.6% | 623,8 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 100 k€ and 250 k€
See the valuationBoard of directors
Source · NBB, accounts to 30/09/20251 active · 1 ended
Active mandates
Heleen Mylle
ActiveEnded mandates
Heleen Mylle
EndedOther companies at this address
Stijn Streuvelsstraat 26 8570 Anzegem| Company | CBE no. |
|---|---|
Apotheek Heleen Mylle● Active | 0811.322.945 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/10/2024 | 01/10/2023 | 01/10/2022 | 01/10/2021 | 01/10/2020 | 01/10/2019 |
| Closing of the financial year | 30/09/2025 | 30/09/2024 | 30/09/2023 | 30/09/2022 | 30/09/2021 | 30/09/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 06/02/2026 | 17/02/2025 | 29/04/2024 | 15/03/2023 | 16/02/2022 | 18/02/2021 |
| General meeting | 18/12/2025 | 14/02/2025 | 24/04/2024 | 08/03/2023 | 03/02/2022 | 01/02/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 11 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 30/09/2025 | 18/12/2025 | 06/02/2026 | Dutch | |
| Abridged model | 30/09/2024 | 14/02/2025 | 17/02/2025 | Dutch | |
| Abridged model | 30/09/2023 | 24/04/2024 | 29/04/2024 | Dutch | |
| Abridged model | 30/09/2022 | 08/03/2023 | 15/03/2023 | Dutch | |
| Abridged model | 30/09/2021 | 03/02/2022 | 16/02/2022 | Dutch | |
| Abridged model | 30/09/2020 | 01/02/2021 | 18/02/2021 | Dutch | |
| Abridged model | 30/09/2019 | 29/12/2019 | 27/01/2020 | Dutch | |
| Abridged model | 30/09/2018 | 13/03/2019 | 14/03/2019 | Dutch | |
| Abridged model | 30/09/2017 | 14/03/2018 | 30/03/2018 | Dutch | |
| Abridged model | 30/09/2016 | 08/03/2017 | 10/03/2017 | Dutch | |
| Abridged model | 30/09/2015 | 09/03/2016 | 31/03/2016 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 100 k€ and 250 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/09/20251 active · 1 ended
Active mandates
Heleen Mylle
ActiveEnded mandates
Heleen Mylle
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025128,2 k €↑
- 2024Annual accounts 202488,8 k €↓
- 2023Annual accounts 202396,8 k €↓
- 2022Annual accounts 202297 k €↑
- 2021Annual accounts 202189,5 k €↑
- 2020Annual accounts 202054,8 k €↑
- 2019Annual accounts 201925,3 k €↓
- 2018Annual accounts 201839,7 k €↓
- 2017Annual accounts 201750,6 k €↑
- 2016Annual accounts 201646,5 k €↑
- 2015Annual accounts 201532,9 k €
- 29/10/2014IncorporationPrivate limited company